These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23867617)

  • 1. New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical.
    Colletti PM
    Clin Nucl Med; 2013 Sep; 38(9):724-5. PubMed ID: 23867617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approves radiopharmaceutical for metastatic prostate cancer.
    Cancer Discov; 2013 Jul; 3(7):OF1. PubMed ID: 23847352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
    Kluetz PG; Pierce W; Maher VE; Zhang H; Tang S; Song P; Liu Q; Haber MT; Leutzinger EE; Al-Hakim A; Chen W; Palmby T; Alebachew E; Sridhara R; Ibrahim A; Justice R; Pazdur R
    Clin Cancer Res; 2014 Jan; 20(1):9-14. PubMed ID: 24190979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    Bruland ØS; Nilsson S; Fisher DR; Larsen RH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases.
    Wissing MD; van Leeuwen FW; van der Pluijm G; Gelderblom H
    Clin Cancer Res; 2013 Nov; 19(21):5822-7. PubMed ID: 24052017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
    Wale DJ; Viglianti BL; Gross MD; Ferretti A; Rubello D; Wong KK
    Am J Clin Oncol; 2019 Jan; 42(1):99-106. PubMed ID: 30204613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
    Cheetham PJ; Petrylak DP
    Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
    Pandit-Taskar N; Larson SM; Carrasquillo JA
    J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-targeting radiopharmaceuticals including radium-223.
    Brady D; Parker CC; O'Sullivan JM
    Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radium - 223 (Xofigo) for prostate cancer.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):79-80. PubMed ID: 24081388
    [No Abstract]   [Full Text] [Related]  

  • 11. Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.
    Borsò E; Boni G; Galli L; Ricci S; Farnesi A; Mazzarri S; Cianci C; Mariani G; Falcone A
    Future Oncol; 2015; 11(2):323-31. PubMed ID: 25075962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radium-223 dichloride for the treatment of metastatic prostate cancer.
    Turner PG; O'Sullivan J
    Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metastases treated with radiopharmaceuticals].
    Giammarile F
    Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct Carcinoma.
    Manfredi M; Airoldi M; Tucci M; Buttigliero C; Parente A; Angusti T
    Clin Nucl Med; 2017 May; 42(5):391-393. PubMed ID: 28166157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223.
    Vogelzang NJ
    Oncology (Williston Park); 2014 Apr; 28(4):296, 298. PubMed ID: 24839800
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radium Ra 223 dichloride in castration-resistant prostate cancer.
    Joung JY; Ha YS; Kim IY
    Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience.
    Kairemo K; Milton DR; Etchebehere E; Rohren EM; Macapinlac HA
    Curr Radiopharm; 2018; 11(2):147-152. PubMed ID: 29956640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
    Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
    Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radium-223 vs EBRT for multiple painful bone metastases: is less more?
    Roach M
    Oncology (Williston Park); 2014 Apr; 28(4):297-8. PubMed ID: 24839801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.